How do you feel about our website?
Great   Indifferent

Psychedelic Entheogenic Medicine

Wyckoff Wellness Center Michael P. Gentile, MD Our Services Psychedelic Medicine
Michael P. Gentile, MD - - Board Certified Psychiatrist

Wyckoff Wellness Center

Michael P. Gentile, MD

Board Certified Psychiatrist located in Wyckoff, NJ

Psychedelic ("mind-manifesting") compounds have a reputation that extends back to the emergence of the counterculture in the 1960s.  During the 1940's, 1950's and 1960's, "classical" psychedelic substances (from nature) like psilocybin from "magic mushrooms" and lysergic acid diethylamide (LSD) were studied extensively and used in clinical settings.  However, in 1970 with the passage of the Controlled Substances Act, psychedelic medicines were classified as Schedule I thought to be highly addictive without any medical value and all research and therapeutic use ceased.

Recent clinical trials demonstrate the benefits of psychedelic medicine for mental health.  Since Johns Hopkins professor Roland Griffiths' landmark study in 2006 ushered in a renaissance in psychedelic research, psychedelic medicines are proving safe, highly therapeutic and anti-addictive.

At Wyckoff Wellness Center in Wyckoff, New Jersey, Dr. Michael Gentile, MD stays up to date with emerging studies and uses of psychedelic medicine to treat psychiatric illnesses.

 

Current State of Psychedelic Medicine

As we await the legalization and availability of psychedelic medicines, several publicly traded companies have received "breakthrough therapy designation" by the FDA for their proprietary formulations:

2017 MDMA for post-traumatic stress disorder (PTSD)

2018 Psilocybin for treatment resistant depression (TRD)

2019 Psilocybin for major depressive disorder (MDD)

2024 LSD for generalized anxiety disorder (GAD)

2024 Psilocybin for major depressive disorder (MDD)

These medicines are undergoing conventional pharmaceutical late stage clinical trials with the goal of earning FDA approval and release.

At the state level, New Jersey is developing a psilocybin program, the details of which may be read by clicking the link below:

https://pub.njleg.state.nj.us/Bills/2024/S2500/2283_I1.PDF

After public hearings, debate, senate vote and an 18-month development period, the Wyckoff Wellness Center will apply for licensure as a psilocybin service center, operator and facilitator.

What we offer

Services